Decision Memo

Vertigo relief app

Record the team verdict, rationale, and reviewer leans locally, then print or share a source-anchored memo.

Markdown export

Agent and email version.

# Decision Memo: Vertigo relief app

Full report: https://ideanavigatorai.com/ideas/vertigo-relief-app/
Recorded: Not recorded

## Decision
- Team verdict: Park
- Validation verdict: Research (56/100)
- Confidence: 58%
- Recommendation: Keep this parked until the team has evidence for the next validation step: Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients.

## Team rationale
No team rationale recorded yet.

## Reviewers
- No named reviewers recorded.

## Source anchors
- Buyer: Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.
- Market: Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space.
- Problem: BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.
- Thesis: Vertigo relief app should be tested as a narrow first-win workflow for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care..
- Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC2117684/
- Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606415/
- Source: https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/home-epley-maneuver
- Source: https://www.ncbi.nlm.nih.gov/books/NBK470308/
- Source: https://growthmarketreports.com/report/digital-vestibular-rehabilitation-platforms-market

## Validation rubric
Rubric version: INAV-VALIDATION-2026-06-04

### Demand signal - 6/10 (24% weight)
Demand looks thin because the report has 4 source-backed signal(s), an editorial confidence of 58/100, and a defined buyer in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space..

- BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC.
- Target buyer: Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.

### Problem severity - 6.3/10 (22% weight)
Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.

- BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.
- BPPV is the most frequent vestibular disorder, with cumulative lifetime prevalence reported between 2.4% and 10%, higher in women (about 3.2% vs 1.6% in men) and rising with age, per population-based epidemiology studies indexed on NIH/PMC.

### Willingness to pay - 5.5/10 (20% weight)
Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.

- Freemium consumer subscription (core maneuver guides free; advanced tracking, history export, and reminders behind a monthly/annual plan) plus a B2B clinic tier where ENT/audiology/physio practices license the app for patient home programs.
- Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients.

### Competitive saturation - 3.9/10 (18% weight)
Competitive room is reduced by 3 recorded alternative(s); the wedge must stay narrow and differentiated.

- Recorded alternative: Vertigo BPPV Vestibular Coach
- Competitive score rewards a narrow wedge, not absence of research.

### Feasibility - 6.2/10 (16% weight)
Feasibility is thin for a moderate build if the MVP is limited to the first measurable workflow.

- Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients.
- Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.

## Market gap
Underserved segments:
- Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. who still run the workflow in spreadsheets, generic docs, email, or chat threads.
- Small teams in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. that feel the pain weekly but are too narrow for broad incumbents.
- New adopters who need guided proof before committing to a larger platform.

Feature gaps:
- A narrow workflow that reaches value without configuration-heavy onboarding.
- A buyer-facing proof artifact that shows time saved, risk reduced, or communication improved.
- A handoff path from manual concierge service to repeatable software.

Differentiation levers:
- Use specificity as the wedge: one buyer, one workflow, one measurable result.
- Show proof earlier than broad competitors with before-and-after examples and small pilot data.
- Keep implementation lighter than incumbent suites or generic AI assistants.

## Roast and risks
Promising enough to test, not strong enough to build broadly.

Blind spots:
- Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.
- A broad AI assistant can flatten differentiation unless the wedge is painfully specific.
- The first release can become a generic dashboard if the job is not named tightly.

Hard questions:
- Who wakes up already trying to solve this?
- What do they stop paying for or stop doing when this works?
- What proof would make a skeptical buyer trust it in one screen?
- What is the smallest paid version of this idea?

## Kill criteria
- Fewer than five qualified buyers agree to discuss the workflow after targeted outreach.
- No buyer can name a current cost in time, money, risk, or reputation.
- The first demo does not produce a clear next step, paid pilot, or specific objection.

## Offer ladder
- **Lead magnet (Free)**: Vertigo Relief App checklist Goal: Capture qualified leads and learn the buyer's exact language. Value: Helps Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. audit the painful workflow before buying software.
- **Frontend offer ($19-$99)**: Concierge review or paid template Goal: Validate urgency, workflow fit, and willingness to pay. Value: Delivers the first useful output manually before automation is trusted.
- **Core offer ($49-$499/month)**: Vertigo relief app focused SaaS Goal: Create the recurring revenue product after the narrow wedge survives tests. Value: Turns the recurring manual workflow into a repeatable product loop.
- **Continuity ($99-$1,000/year add-on)**: Monitoring, benchmarks, and monthly reporting Goal: Increase retention and make the product part of a routine. Value: Keeps the buyer engaged with ongoing proof, saved time, or reduced risk.
- **Backend offer (Custom)**: Done-with-you setup, agency, or team rollout Goal: Capture higher-value accounts once the productized wedge is proven. Value: Adds implementation help, integrations, and workflow migration.

Print-ready memo

Decision Memo: Vertigo relief app

Team verdict: Park
Validation verdict: Research / 56/100
Confidence: 58%
Recorded: Not recorded

Recommendation

Keep this parked until the team has evidence for the next validation step: Build a lightweight landing page plus a no-code guided-Epley walkthrough and run targeted ads to vertigo/BPPV search terms; measure email signups and the share who complete the maneuver flow. Validate B2B demand by pitching 10-15 ENT/audiology/physio clinics on recommending it for between-visit home care and counting how many agree to trial it with patients.

Team rationale

No team rationale recorded yet.

Reviewers

No named reviewers recorded.

Source anchors

Buyer: Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care.
Market: Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space.
Problem: BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.
Thesis: Vertigo relief app should be tested as a narrow first-win workflow for Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care..

Validation rubric

Demand signal

24% weight

6/10

Demand looks thin because the report has 4 source-backed signal(s), an editorial confidence of 58/100, and a defined buyer in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space..

Problem severity

22% weight

6.3/10

Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.

Willingness to pay

20% weight

5.5/10

Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.

Competitive saturation

18% weight

3.9/10

Competitive room is reduced by 3 recorded alternative(s); the wedge must stay narrow and differentiated.

Feasibility

16% weight

6.2/10

Feasibility is thin for a moderate build if the MVP is limited to the first measurable workflow.

Market gap

Underserved segments

Adults (skewing female and older) suffering recurrent positional vertigo/BPPV, plus ENT clinics, audiologists, and vestibular physiotherapists who could recommend or white-label the app for between-visit home care. who still run the workflow in spreadsheets, generic docs, email, or chat threads.
Small teams in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space. that feel the pain weekly but are too narrow for broad incumbents.
New adopters who need guided proof before committing to a larger platform.

Feature gaps

A narrow workflow that reaches value without configuration-heavy onboarding.
A buyer-facing proof artifact that shows time saved, risk reduced, or communication improved.
A handoff path from manual concierge service to repeatable software.

Differentiation levers

Use specificity as the wedge: one buyer, one workflow, one measurable result.
Show proof earlier than broad competitors with before-and-after examples and small pilot data.
Keep implementation lighter than incumbent suites or generic AI assistants.

Roast and risks

Promising enough to test, not strong enough to build broadly.

Blind spots

Regulatory and medical-claims risk: positioning the app as treating or curing BPPV can trigger FDA software-as-a-medical-device scrutiny and liability; marketing must stay within wellness/educational claims and carry medical disclaimers.
A broad AI assistant can flatten differentiation unless the wedge is painfully specific.
The first release can become a generic dashboard if the job is not named tightly.

Hard questions

Who wakes up already trying to solve this?
What do they stop paying for or stop doing when this works?
What proof would make a skeptical buyer trust it in one screen?
What is the smallest paid version of this idea?

Kill criteria

Fewer than five qualified buyers agree to discuss the workflow after targeted outreach.
No buyer can name a current cost in time, money, risk, or reputation.
The first demo does not produce a clear next step, paid pilot, or specific objection.

Offer ladder

Lead magnet